Use of Three-Dimensional Printed Models for Endovascular Planning and Follow-up in Patients Affected by Aorto-Iliac-Femoral-Popliteal Arterial Disease Undergoing Balloon Angioplasty. A Single-center, Single-blind Randomized Controlled Trial
Key facts
- Who runs it
- Azienda Ospedaliero-Universitaria di Parma
- Where
- Italy1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 100 people enrolled
- Started
- 5 Jan 2022
- Ended
- 30 Sept 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- PTA planning supported by 3D-printed model
- PTA (Standard of Care)
- Record updated
- 2 June 2025
Who can take part
- Age
- 18 years to 89 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Age between 18 and 89 years
- Severe claudication or critical limb ischemia (Rutherford categories 3-5 [Cronenwett and Johnston. Rutherford's Vascular Surgery 7th edition. Saunders Elsevier 2010]) and indication already established for endovascular revascularization treatment (according to the current Italian SICVE guidelines)
- Atherosclerotic disease involving the aorto-iliac-femoro-popliteal segment
- Signed informed consent
Who cannot take part
- Atherosclerotic disease limited to tibial vessels only (absent or non-significant atherosclerosis at aorto-iliac-femoro-popliteal level)
- Age <18 years or >89 years
- Preoperative CTA not available for any reason (clinical contraindication, logistical impossibility)
- Patients requiring urgent intervention (lack of time for 3D model printing)
- Patient refusal to participate in the study
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Lower extremity peripheral arterial disease is a major health problem. Currently, balloon angioplasty represents the most commonly performed treatment for patients affected by vascular claudication or critical limb ischemia. Pre-operative planning for aorto-iliac-femoral-popliteal atherosclerotic disease is a complex procedure, since an inappropriate strategy may lead to peri-operative complications. The aim of this study is to propose an innovative planning strategy for balloon angioplasty with the support of complex 3D printed models. The goal is to reduce peri-operative complications and overall costs, while improving technical success and mid-term patency of revascularizations.
The 2 groups in the trial
- Preoperative planning performed based on CTA (standard of care)Existing treatment, for comparison
Treatment: PTA (Standard of Care)
- Preoperative planning performed using CTA and a patient-specific, custom-made 3D-printed modelTreatment being tested
Treatment: PTA planning supported by 3D-printed model
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Use of Three-Dimensional Printed Models for Endovascular Planning and Follow-up in Patients Affected by Aorto-Iliac-Femoral-Popliteal Arterial Disease Undergoing Balloon Angioplasty: Applicability, Effectiveness in Technical Success and on Mid-Term Outcomes, Cost-Analysis, and Exploration of New Technologies. A Single-center, Single-blind Randomized Controlled Trial
- Publications
- Custom Made Three Dimensional Printed Models for Pre-operative Planning and Simulation of Endovascular Treatment of Peripheral Artery Disease (3DPAD-1): A Single Blind Randomised Controlled Trial.European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2026
- Record updated
- 2 June 2025